本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Kymera Therapeutics, Inc.

116.04
+2.892.55%
成交量:18.84萬
成交額:2,178.16萬
市值:96.48億
市盈率:-36.12
高:116.97
開:113.06
低:112.88
收:113.15
52周最高:130.05
52周最低:47.86
股本:8,315.06萬
流通股本:6,487.46萬
量比:0.64
換手率:0.29%
股息:- -
股息率:- -
每股收益(TTM):-3.2122
每股收益(LYR):-3.6900
淨資產收益率:-24.15%
總資產收益率:-15.59%
市淨率:6.39
市盈率(LYR):-31.45

資料載入中...

2026/06/25

重要事件披露

Form 8-K - Current report
2026/06/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/24

重要事件披露

Form 8-K - Current report
2026/06/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/09

重要事件披露

Form 8-K - Current report
2026/05/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/15

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]